Mon, June 24, 2024
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024
Mon, June 17, 2024

Eliana Merle Downgraded (ZNTL) to Hold and Decreased Target to $5 on, Jun 20th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-5-on-jun-20th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eliana Merle of UBS, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $28 to $5 on, Jun 20th, 2024.

Eliana has made no other calls on ZNTL in the last 4 months.



There are 6 other peers that have a rating on ZNTL. Out of the 6 peers that are also analyzing ZNTL, 3 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $9 on, Tuesday, June 18th, 2024
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $8 on, Tuesday, June 18th, 2024
  • Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024


These are the ratings of the 3 analyists that currently disagree with Eliana


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, June 18th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, June 18th, 2024
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Tuesday, June 18th, 2024

Publication Contributing Sources